OTCMKTS:CLVLY

Clinuvel Pharmaceuticals Competitors

$22.51

-0.06 (-0.24 %)

(As of 04/13/2021 02:47 PM ET)

Add

Compare

Today's Range

$22.51

Now: $22.51▼

$22.51

50-Day Range

$15.91

MA: $19.96▼

$22.86

52-Week Range

$12.56

Now: $22.51▼

$22.90

Volume210 shs

Average Volume7,290 shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) Vs. DDXS, TNGN, ATTBF, ACHL, ADTX, and AGNPF

Should you be buying CLVLY stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Clinuvel Pharmaceuticals, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Achilles Therapeutics plc American Depositary Shares (ACHL), ADiTx Therapeutics (ADTX), and Algernon Pharmaceuticals (AGNPF).

Clinuvel Pharmaceuticals vs. (DDXS) Stock

(DDXS) (OTCMKTS:DDXS) and Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares (DDXS) and Clinuvel Pharmaceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(DDXS)	N/A	N/A	N/A
Clinuvel Pharmaceuticals	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (DDXS) and Clinuvel Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(DDXS)	0	0	0	0	N/A
Clinuvel Pharmaceuticals	0	0	1	0	3.00

Valuation & Earnings

This table compares (DDXS) and Clinuvel Pharmaceuticals' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(DDXS)	N/A	N/A	N/A	N/A	N/A
Clinuvel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Summary

Clinuvel Pharmaceuticals beats (DDXS) on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals vs. (TNGN) Stock

(TNGN) (OTCMKTS:TNGN) and Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) are both health technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares (TNGN) and Clinuvel Pharmaceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
(TNGN)	N/A	N/A	N/A
Clinuvel Pharmaceuticals	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (TNGN) and Clinuvel Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
(TNGN)	0	0	0	0	N/A
Clinuvel Pharmaceuticals	0	0	1	0	3.00

Valuation & Earnings

This table compares (TNGN) and Clinuvel Pharmaceuticals' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
(TNGN)	N/A	N/A	N/A	N/A	N/A
Clinuvel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Summary

Clinuvel Pharmaceuticals beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals vs. Abattis Bioceuticals Stock

Abattis Bioceuticals (OTCMKTS:ATTBF) and Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Abattis Bioceuticals and Clinuvel Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abattis Bioceuticals	0	0	0	0	N/A
Clinuvel Pharmaceuticals	0	0	1	0	3.00

Profitability

This table compares Abattis Bioceuticals and Clinuvel Pharmaceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Abattis Bioceuticals	N/A	N/A	N/A
Clinuvel Pharmaceuticals	N/A	N/A	N/A

Valuation & Earnings

This table compares Abattis Bioceuticals and Clinuvel Pharmaceuticals' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abattis Bioceuticals	N/A	N/A	N/A	N/A	N/A
Clinuvel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Summary

Clinuvel Pharmaceuticals beats Abattis Bioceuticals on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals vs. Achilles Therapeutics plc American Depositary Shares Stock

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) and Achilles Therapeutics plc American Depositary Shares (NASDAQ:ACHL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clinuvel Pharmaceuticals	0	0	1	0	3.00
Achilles Therapeutics plc American Depositary Shares	0	0	0	0	N/A

Profitability

This table compares Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Clinuvel Pharmaceuticals	N/A	N/A	N/A
Achilles Therapeutics plc American Depositary Shares	N/A	N/A	N/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and Achilles Therapeutics plc American Depositary Shares' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clinuvel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
Achilles Therapeutics plc American Depositary Shares	N/A	N/A	N/A	N/A	N/A

Summary

Clinuvel Pharmaceuticals beats Achilles Therapeutics plc American Depositary Shares on 1 of the 1 factors compared between the two stocks.

Clinuvel Pharmaceuticals vs. ADiTx Therapeutics Stock

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) and ADiTx Therapeutics (NASDAQ:ADTX) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for Clinuvel Pharmaceuticals and ADiTx Therapeutics, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clinuvel Pharmaceuticals	0	0	1	0	3.00
ADiTx Therapeutics	0	0	1	0	3.00

Profitability

This table compares Clinuvel Pharmaceuticals and ADiTx Therapeutics' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Clinuvel Pharmaceuticals	N/A	N/A	N/A
ADiTx Therapeutics	N/A	N/A	N/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and ADiTx Therapeutics' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clinuvel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
ADiTx Therapeutics	N/A	N/A	N/A	N/A	N/A

Clinuvel Pharmaceuticals vs. Algernon Pharmaceuticals Stock

Clinuvel Pharmaceuticals (OTCMKTS:CLVLY) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, institutional ownership, profitability and risk.

Analyst Ratings

This is a summary of current ratings for Clinuvel Pharmaceuticals and Algernon Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Clinuvel Pharmaceuticals	0	0	1	0	3.00
Algernon Pharmaceuticals	0	0	0	0	N/A

Profitability

This table compares Clinuvel Pharmaceuticals and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Clinuvel Pharmaceuticals	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A

Valuation and Earnings

This table compares Clinuvel Pharmaceuticals and Algernon Pharmaceuticals' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Clinuvel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
Algernon Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Summary

Clinuvel Pharmaceuticals beats Algernon Pharmaceuticals on 1 of the 1 factors compared between the two stocks.